IMM 0.00% 37.0¢ immutep limited

radical ovarian cancer treatment, page-2

  1. 978 Posts.
    thanks Boiler, I appreciate all the good research you are doing here.

    I hope for ovavian cancer sufferers' sake that this, like CVac, is found to be effective, but it may be many years before it becomes widely available since it is only in the early stages of research just like CVac was in 2002.

    I imagine if it is effective it could eventually work alongside CVac to increase the % of women who survive after treatment. There are enough ovarian cancer sufferers in the world to fully accomodate the range of different technologies which in the future will become available.

    However, CVac has the advantage of being the first of these likely to become commercial and available throughout a large part of the world since scientist have been working on it for 18 years now and after showing its efficacy in all its clinical trials to date, CVac has only a bit further to go before official approval.

    cheers

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
0.000(0.00%)
Mkt cap ! $537.4M
Open High Low Value Volume
37.0¢ 38.3¢ 36.5¢ $1.060M 2.841M

Buyers (Bids)

No. Vol. Price($)
3 48648 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 13814 2
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.